A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant enterococcus faecali
dc.contributor.author | Munita, José | |
dc.contributor.author | Tran, Truc | |
dc.contributor.author | Diaz, Lorena | |
dc.contributor.author | Panesso, Diana | |
dc.contributor.author | Reyes, Jinnethe | |
dc.contributor.author | Murray, Barbara | |
dc.contributor.author | Arias, Cesar | |
dc.date.accessioned | 2017-04-18T13:42:51Z | |
dc.date.available | 2017-04-18T13:42:51Z | |
dc.date.issued | 2013 | |
dc.description.abstract | The genetic bases for antibiotic tolerance are obscure. Daptomycin (DAP) is a lipopeptide antibiotic with bactericidal activity against enterococci. Using time-kill assays, we provide evidence for the first time that a deletion of isoleucine in position 177 of LiaF, a member of the three-component regulatory system LiaFSR involved in the cell envelope response to antimicrobials, is directly responsible for a DAP-tolerant phenotype and is likely to negatively affect response to DAP therapy. | |
dc.format.extent | 3 | |
dc.identifier.citation | Antimicrobial Agents Chemotherapy, 2013,57(6):2831-3 | |
dc.identifier.uri | http://hdl.handle.net/11447/1164 | |
dc.identifier.uri | http://dx.doi.org/10.1128/AAC.00021-13 | |
dc.language.iso | en_US | |
dc.publisher | American Society for Microbiology | |
dc.subject | Bacterial Proteins/genetics | |
dc.subject | Codon/genetics | |
dc.subject | Daptomycin/pharmacology | |
dc.subject | Drug Resistance, Bacterial/genetics | |
dc.subject | Enterococcus faecium/drug effects | |
dc.subject | Sequence Deletion/genetics | |
dc.title | A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant enterococcus faecali | |
dc.type | Artículo |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A liaF Codon Deletion Abolishes Daptomycin Bactericidal Activity against Vancomycin-Resistant.pdf
- Size:
- 349.97 KB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo